Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)

CAS: 9003-11-6

Ref. 3D-FP158004

Informação sobre produto

• Nome: Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol)
• Sinónimos: Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) - average MW -5,800, 333E, 50Mb-26X, 75H380000, 75H90000, 75Hb1440, 80De40U, Bloatguard, CE, Exocorpol, Kwc-Q, Magcyl, Nixolen, Oxalgon, PAG, Poloxalcol, Poloxalene, Poloxalkol, Polyoxyethylene-polyoxypropylene, Proksanol, Proxanol, Regulaid, Slovanik, Vepoloxamer, α-Hydro-ω-hydroxy-poly(oxyethylene)-poly(oxypropylene), Glycols, polyethylene-polypropylene, Oxirane, 2-methyl-, polymer with oxirane, Oxirane, polymer with methyloxirane, Oxirane, methyl-, polymer with oxirane, Propylene oxide, polymer with ethylene oxide

Descrição

Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) is a polymeric drug that has been synthesized to inhibit the activity of P-glycoprotein. This polymer is used to control the uptake of drugs into cells. It also has shown an effect on cancer cell viability, ATP levels, and hydrogen bond formation in vitro. Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) has also been found to be a nonsteroidal anti-inflammatory drug (NSAID). NSAIDs are used for the treatment of pain and inflammation caused by diseases such as osteoarthritis or rheumatoid arthritis. NSAIDs work by inhibiting cyclooxygenase, which is an enzyme that produces prostaglandins from arachidonic acid. The inhibition of prostaglandin synthesis leads to reduced inflammation and pain. NSAIDs can cause side effects

• Marca: Biosynth

Propriedades químicas

• Fórmula: (C₃H₆O•C₂H₄O)x
• Pureza: Min. 95%
• Cor/forma: Solid